Overview

Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This is an open label, randomised, balanced, two-treatment, two-period, two-sequence, crossover, oral bioequivalence study.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Diphosphonates
Ibandronic Acid